The Effect of Statin on Epithelial-Mesenchymal Transition in Peritoneal Mesothelial Cells

Tumor Necrosis Factor α Decreases Nitric Oxide Synthase Type 3 Expression Primarily via Rho/Rho Kinase in the Thick Ascending Limb

(2012) Vanesa D. Ramseyer et al.   HYPERTENSION

The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial–mesenchymal transition of peritoneal mesothelial cells

(2012) Sun Ha Lee et al.   LABORATORY INVESTIGATION

The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions

(2011) Bo Young Nam et al.   APOPTOSIS

Epithelial–mesenchymal transition of rat peritoneal mesothelial cells via Rhoa/Rock pathway

(2010) Hao Zhang et al.   IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease

(2008) Linda F. Fried   KIDNEY INTERNATIONAL

Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways

(2008) Raquel Rodrigues-Díez et al.   PHARMACEUTICAL RESEARCH

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

(2008) Chao-Yung Wang et al.   TRENDS IN MOLECULAR MEDICINE

A New Look at Platelet-Derived Growth Factor in Renal Disease

(2007) J. Floege et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY